|
Workshops
Workshop 1: Implant loosening
- Ove Furnes (Helse
Bergen, Norway): Epidemiology of aseptic loosening
- Mark Wilkinson
(Sheffield, UK): Pathogenesis of loosening
- Kjeld Soballe (Aarhus, Denmark): Biologic
treatment strategies
Workshop 2: Proteomics
- Irina Kratchmarova (Odense, Denmark): Quantitative
proteomics for cell differentiation in bone development
- Mathias Mann (Munich, Germany): Proteomics
technology
- Claes Lindberg
(Lund, Sweden): Biomarker discovery
Workshop 3: Kidney and bone disease
- John Cunningham
(London, UK): Calcimimetics and hyperparathyroidism
- Marcus Ketteler
(Aachen, Germany): The bone -vascular interface
- Klaus Olgaard (Copenhagen, Denmark): Vitamin
D (deficiency/sufficiency) and the new active compounds
Workshop 4: GPCR
- Stephen Hill (Nottingham, UK): GPCR receptor
signalling
- Ruth Ross (Aberdeen,
UK): Cannabinoids and bone
- Mone Zaidi (New
York, USA): New roles for GPCR ligands
Workshop 5: Clinical cases
To be selected from submitted abstracts
Workshop 6: New models/novel approaches
- Martin Hrabé de Angelis
(Munich, Germany): ENU and mice
- Marie-André Akimenko (Ottawa, Canada):
Zebrafish
- A Francis Stewart
(Dresden, Germany): Current and future issues in mouse genome
engineeringBody text here.
|
|
|